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Our previous studies had shown that platelet activating factor
(PAF) was an important mediator of vascular leak. We found that
although the dengue virus (DENV) or dengue immune serum did
not induce PAF production by monocytes, lipopolysaccharide (LPS)
acted synergistically with the DEN, in the production of PAF. Since
LPS levels in serum have been found to be signiﬁcantly elevated
in SD, LPS could further contribute to disease pathogenesis and
vascular leak.
Mast cells are an important source of PAF and have shown to
be important in disease pathogenesis in dengue mice models. We
found thatmediators such as tryptase and secretoryphospholipase,
which are produced exclusively by mast cells, are signiﬁcantly ele-
vated in patients with DHF, during early infection. Therefore, in
summary, the events that lead to severe dengue appear to occur
before the onset of vascular leak and the role of mast cells and viral
proteins in the pathogenesis of SD should be further investigated.
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Management of severe dengue
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Abstract: Dengue is an important human arboviral disease
caused by infection of four antigenically related strains of dengue
virus (DENV 1-4) belonging to the Flaviviridae family. Despite
extensive worldwide efforts, it remains a major public health con-
cern with 55% of the world’s population estimated to be at risk
for dengue. Infection by any of the four dengue serotypes can
cause a wide spectrum of disease manifestations that ranges from
mild, self-limiting febrile dengue fever to severe, life-threatening
disease. The pathophysiological hallmark that determines disease
severity is the degree of plasma leakage, bleeding and single or
mutli-organ involvement. In recent years, there were several clini-
cal trials using re-purposed pharmaceutical agents to treat dengue,
however none has shown signiﬁcant usefulness for its recommen-
dation for routine use. Lacking the anti-viral agents, management
of dengue is largely supportive in nature. Ability to recognise infec-
tion early and early signs of disease progression remain key in
instituting early and appropriate interventions, preventing dis-
ease progression or late presentation of disease where treatment
options are limited and outcomes are poor. Patients with severe
dengue should be admitted to a hospital with access to intensive
care facilities. Judicious intravenous ﬂuid replacement is critical
to balance the 2 stages between plasma leakage and ﬂuid re-
absorption during recovery phase. Dengue is a dynamic disease
particularly so during the critical phase where plasma volume
changes rapidly, close and frequent monitoring of hematocrit is
critical to guide ﬂuid replacement. Concealed bleeding may pose a
clinical challenge and in instance blood transfusionmay be needed.
Denguemortality can be reducedwith systempriming to recognise
the disease and systematic treatment approach.
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Leptospirosis
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Abstract: Leptospirosis is present worldwide and is especially
important in developing countries, where sanitation is precari-
ous. Sporadic cases are linked to contact with urine-contaminated
water. In tropical countries, urban outbreaks can occur after ﬂoods
in rainy season. Mild non-lethal anicteric forms comprise most
cases and can be easily confused with ﬂu, dengue fever, other
mild viral illnesses and P. vivax malaria. About 5 to 10% of cases
develop severe sepsis-like disease or meningitis during outbreaks.
The serious illness form, also known as Weil’s Disease, courses
with jaundice, shock, renal failure, coagulopathy and other organ
dysfunctions, leading to prolonged hospitalization in intensive
care facilities and death, with high healthcare costs. Differential
diagnosis includes bacterial sepsis, hepatitis, yellow fever, Han-
tavirus disease, P. falciparum malaria and other severe febrile
illnesses. Highly sensitive and speciﬁc rapid diagnosis tests are
commercially lacking. Antibodies or antigen detection by enzyme-
linked assays and nucleic acid detection by PCR in blood or
other body ﬂuids are promising. Mechanisms of disease are little
known, but evidence points out to systemic inﬂammatory response
syndrome-like pathophysiology in severe cases. Spirochete cell
wall proteins, lipopolysaccharide, enzymes like phospholipase and
other bacterial toxic products produce tissue damage and activate
inﬂammatory response locally and systemically, through toll-like
receptors on antigen-presenting cells, triggering cytokine secretion
by innate andadaptive immunecells, resulting in inﬂammatoryand
immune responses. Some patients evolve with shock, coagulopa-
thy, organ failure and death. Which regulatory mechanism leads
to severe disease is not exactly known. Lethality varies widely in
severe cases, reaching 50% in some reports, depending of diagno-
sis and treatment institution speed, level of care and other factors.
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Better comprehension of disease immunopathogeny can lead to
adequate treatment and prevention.
http://dx.doi.org/10.1016/j.ijid.2016.02.130
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Leprosy: Is it a disease to be neglected?
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Abstract: On 31st December 2005 we realized that India had
reached the goal of Eliminating Leprosy. This was quite pleasing
since we had failed to reach the goal in 2000, as originally sched-
uled. This was also quite surprising for a country which had an
annual new case detection rate of more than 4 per 10,000 pop-
ulation. Leprosy with its long incubation period and sub-clinical
carriage did not appear to be a disease whose incidence can be
reduced by treating clinical cases. This presentation is aimed at
providing insights into the circumstance leading to elimination of
leprosy and its implications.
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Parasitic infections and allergies
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Abstract: The hygiene hypothesis has been proposed to explain
temporal trends of increasing allergy prevalence in high-income
countries and in urbanizing populations in low-income countries
(LICs). Improvements in hygiene and reductions in exposures to
childhood infectious diseases are considered to cause increased
allergy through a failure to educate appropriately the develop-
ing immune system leading to inadequate regulation of allergic
inﬂammation. Parasite infections are extremely common in poor
populations in LICs and a high prevalence of parasites, par-
ticularly helminth parasites, has been put forward to explain
the low prevalence of allergy in rural populations of LICs.
Data from epidemiological studies in populations infected with
helminth parasites have provided strong evidence that exposures
to helminth infections attenuate atopy and Th2 inﬂammatory
responses directed against aeroallergens. Further, helminth expo-
sures appear to modify the effects of atopy on allergic diseases (i.e.
asthma, rhinitis, and eczema). However, exposures to some para-
sites with a life cycle phase of pulmonary migration may increase
the risk of wheeze. For example, half the cases of wheeze in a rural
case-control studywere attributable to evidence of allergic sensiti-
zation to ascariasis, while two thirds of acute bronchospasm in an
urban setting was attributable to house dust mite IgE. Helminths
may, therefore, be the primary target of allergic responses in tra-
ditional rural populations and such responses may be subject to
immuneregulation leading toamilder clinical courseof allergicdis-
eases. In contrast, inurbanizingpopulationswhere the introduction
of sanitation may lead to the gradual disappearance of helminth
infections, aeroallergens may emerge as the primary allergic sensi-
tizers, and because such responses may be subject to less rigorous
regulation, could cause more severe disease. Prospective studies
from birth in populations undergoing the process of urbanization
arehelping todeﬁne the roleof exposures tohelminthparasites and
other childhood parasitic infections in the changing epidemiology
of allergic disease in LICs.
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Infectious disease pathology in India:
Interactive cases
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Abstract: India is in a unique position in that Indian clinicians
and pathologists encounter both diseases endemic to other tropical
and developing countries, as well as healthcare and immunosup-
pression associated infectionsmore typical of developed countries.
This interactive session will discuss several cases that illustrate the
varied clinical presentationsof infectiousdiseases, their differential
diagnosis and correlate the clinical with the pathological ﬁndings
in these patients.
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Hepatitis C infection in people who inject drugs
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Abstract: Hepatitis C virus (HCV) is a major global public health
problem. Worldwide, ∼184 million people are infected, with a
higher prevalence in developing countries compared to developed
countries in North America and Europe. However, vulnerable pop-
ulations (e.g., people who inject drugs (PWID), Aboriginal people,
and incarcerated individuals) account for >80% of new infections
andmost of the onward transmission. In Bangladesh, PWIDaccount
for the vast majority of HCV infections.
